Understanding how sex affects HIV infection and treatment outcomes
Deciphering the impact of sex in early subtype C HIV infection and during HART
This study is looking at how HIV affects men and women differently in Zambia, especially focusing on why women often have lower viral loads but face unique health challenges, with the goal of finding better treatment options for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10880661 on NIH RePORTER |
What this research studies
This research investigates the differences in HIV infection and treatment outcomes between men and women, focusing on subtype C HIV-1 in Zambian patients. By analyzing samples from both sexes, the study aims to uncover how viral, immunological, and hormonal factors contribute to the disease's progression and response to treatment. The research will explore why women, despite having more activated immune cells, often have lower viral loads and face different health challenges compared to men. This comprehensive approach seeks to provide insights that could lead to improved treatment strategies tailored to each sex.
Who could benefit from this research
Good fit: Ideal candidates for this research are Zambian individuals who are acutely infected with subtype C HIV-1, particularly those who can provide samples for analysis.
Not a fit: Patients who are not acutely infected with HIV or those outside the Zambian population may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized HIV treatment strategies for both men and women.
How similar studies have performed: Previous research has shown that understanding sex differences in disease can lead to significant advancements in treatment, suggesting that this approach has the potential for success.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Hunter, Eric — Emory University
- Study coordinator: Hunter, Eric
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.